This finding is corroborated by Malakar P., et al, who recently suggested a role for increased MALAT1 expression in the development of HCC through interaction with serine and arginine-rich splicing factor 1 and activation of mTOR signaling [22]. This evidence concerns the gene MTOR and hepatocellular carcinoma.